In order to build a better map of the brain, begin by slicing glass windows into the glowing skulls of genetically-engineered mice.
Transhuman Terminology.
ADHOCRACY
AEONOMICS
A-LIFE
AGORIC SYSTEM
AI-COMPLETE ALEPH ALGERNON AMORTALIST ARACHNIOGRAPHY ARCH-ANARCHY ARCOLOGY ARROW IMPOSSIBILITY THEOREM ARTILECT ASEX ASIMORT ASIMOV ASSEMBLER ATHANASIA ATHANOPHY ATHEOSIS AUGMENT AUTOEVOLUTIONIST AUTOMATED ENGINEERING AUTOMORPHISM AUTOPOTENT AUTOSCIENT BABY UNIVERSE BASEMENT UNIVERSE BEAN DIP CATASTROPHE BEANSTALK BEKENSTEIN BOUND BERSERKER BETELGEUSE-BRAIN BIG CRUNCH BINERATOR BIOCHAUVINISM BIOLOGICAL FUNDAMENTALISM BIONICS BIONOMICS BIOPHILIAC BIOSTASIS B-LIFE BLIGHT BLIND UPLOADING BLUE GOO BOGOSITY FILTER BORGANISM BREAKEVEN POINT BROADCATCHING BRUTE FORCE UPLOADING BUSH ROBOT CALCUTTA SYNDROME CALM TECHNOLOGY CALORIE RESTRICTION CASIMIR EFFECT CEREBROSTHESIS CHINESE ROOM CHRONONAUTS CHURCH-TURING THESIS COBOTS COMPUFORM COMPUTRONIUM CONCENTRATED INTELLIGENCE CONSILIENCE CONNECTIONISM CONTELLIGENCE CONTINUITY IDENTITY THEORY COSMYTHOLOGY CRYOBIOLOGY CRYOCRASTINATE CRYOGENICS CRYONICS CRYONIC SUSPENSION CRYPTO ANARCHY CRYPTOCOSMOLOGY CYBERCIDE CYBERFICTION CYBERGNOSTICISM CYBERIAN CYBERNATE/CYBERNIZE CYBERSPACE/CYBERMATRIX CYBRARIAN CYPHERPUNK DEANIMALIZE DEATH FORWARD DEATHISM DEEP ANARCHY DEFLESH DIGITAL PSEUDONYM DIAMONDOID DISASSEMBLER DISASTERBATION DISTRIBUTED INTELLIGENCE DIVERGENT TRACK HYPOTHESIS DIVERSITY IQ DIVIDUALS DOOMSDAY ARGUMENT DOWNLOAD DRYWARE DUBIFIER DYSON SPHERE ECOCALYPSE ECTOGENESIS
EMBRYOMEME
EMULATION
ENHANCED REALITY
ENVIROCAPITALISM
EPHEMERALISTS
E-PRIME
ESCALATORLOGY
THE ETERNAL LIFE POSTULATE
EUPSYCHIA
EUTHENICS
EVOLUTIONARILY STABLE STRATEGY (ESS)
EVOLUTURE
EXCONOMICS
EXES
EXFORMATION
EXISTENTIAL TECHNOLOGY
EXOPHOBIA
EXOSELF
EXTROPIAN
EXTROPIATE
EXTROPIC
EXTROPOLIS
EXTROPY
FACULTATIVE ANAGOROBE
FAR EDGE PARTY
THE FERMI PARADOX
FEMTOTECHNOLOGY
FLATLANDER
FLUIDENTITY
FOGLET
FORK
FREDKIN’S PARADOX
FUNCTIONAL SOUP
FUTIQUE
FUTURE SHOCK
GALAXY BRAIN
GAUSSIAN
GENEGENEERING
GENETIC ALGORITHM
GENIE
GREEN GOO
GÖDEL’S THEOREM
GOLDEN GOO
GREAT FILTER, THE
GREY GOO
GUY FAWKES SCENARIO
HALLUCINOMEMIC
HIVE COMPUTING
HOMORPH
HPLD
HYPERTEXT
HYPONEIRIA
HYPOTECH
IDEAL IDENTITY
IMMORTALIST
IMMORTECHNICS
IMP
INACTIVATE
INFOGLUT
INFOMORPH
INFORMATION-THEORETICAL DEATH
INLINE UNIVERSITIES
INTERFACER
INTERNALNET
JUPITER-BRAIN
KHAKI GOO
KARDASCHEV TYPES
KNOWBOTS
KOLMOGOROV COMPELXITY
LEONARDO DA VINCI SYNDROME
LINDE SCENARIO
LIQUIDENTITY
LOFSTROM LOOP
LONGEVIST
MASPAR
MATAGLAP
MEGATECHNOLOGY (or MEGASCALE ENGINEERING)
MEMETICS
MEMIE
MEMIUS
MEMOTYPE
MEMOID (or MEMEOID)
MEHUM
MERCHANCY
MESOSCALE
MINDKIND
MOLMAC
MORPHOLOGICAL FREEDOM
MUTUAL REALITY
NANARCHIST
NANARCHY
NANITE
NANOCHONDRIA
NANOFACTURE
NANOMEDICINE
NANOSOME
NANOTECH
(MOLECULAR) NANOTECHNOLOGY
NEG
NEOMORPH
NEOLOGOMANIA
NEOPHILE
NEOPHILIA
NEOPHOBE
NEUROCOMPUTATION
NEURONAUT
NEURON STAR
NEUROPROSTHESIS
NEUROSUSPENSION
NOOTROPIC
NOW SHOCK
NUTRACEUTICAL
OFFLOADING
OMEGA POINT
OMEGON
OMNESCIENCE
O’NEILL COLONY
O’NEILL CYLINDERS
ONTOLOGICAL CONSERVATIVES
OPTIMAL PERSONA
PANCRITICAL RATIONALISM
ORBITAL TOWER
PARTIALATE
PATTERN IDENTITY THEORY
PERICOMPUTER
PERIMELASMA
PERSOGATE
PERVERSION ATTACK
PHARMING
PHYLE
PHYSICAL ESCHATOLOGY
PICO TECHNOLOGY
PIDGIN BRAIN
PINK GOO
PLEXURE
POME
POSTHUMAN
POSTJUDICE
POWERSHIFT
PRISONERS’ DILEMMA
PRIVACY MANAGEMENT
PROLONGEVITY
QUANTUM COMPUTING
QUANTUM CRYPTOGRAPHY
QUASISPECIES
RAPTURE OF THE FUTURE
RED GOO
RED QUEEN PRINCIPLE
RED QUEENED
REMEMBRANCE AGENT
REVERSIBLE
RIF
SANS CEILING HYPOTHESIS
SANTA MACHINE
SAPPER MEME
SCHEME
SENTIENCE QUOTIENT
SHIH
SINGULARITY
SINGULARITARIAN
SKY HOOK
SMART-FACED
SOCIOTYPE
SOLID STATE CIVILIZATION
SPIKE, THE
SPOCK MEME
SPONTANEOUS VOLUNTARISM
SPACE FOUNTAIN
STAR LIFTING
STELLAR HUSBANDRY
STEWARD
STRONG AI POSTULATE
STRONG CONVERGENCE HYPOTHESIS
SUSPENDED ANIMATION
SYNTHESPIAN
TAZ/Temporary Autonomous Zone.
TECHNOCYTE
TECHNOSPHERE
TECHNOCALYPS
TELEOLOGICAL THREAD
THEORETICAL APPLIED SCIENCE
TITHONUS SYNDROME
TIPLER CYLINDER
TIPLERITE
TRANSBIOMORPHOSIS (TRANSBIOLOGICAL METAMORPHOSIS)
TRANSCEND
TRANSCENSION
TRANSCIENT
TRANSCLUSION
TRANSHUMANISM
TRANSHUMANITIES
TRAPDOOR FUNCTION
TURING MACHINE
TURING TEST
ÜBERGOO
UBIQUITOUS COMPUTING
UPLIFT
UPLOADER
UNIVERSAL CONSTRUCTOR
UNIVERSAL IMMORTALISM
UNIVERSAL TURING MACHINE
UTILITY FOG
VACCIME
VASTEN
VENTURISM
VIEWQUAKE
VIRIAN
VIRION
VIRTUAL COMMUNITY
VIRTUAL RIGHTS
VITOLOGY
VIVISYSTEM
VON NEUMANN MACHINE
VON NEUMANN PROBE
WEBORIZE
WETWARE
WORMHOLE
XENOBIOLOGY
XENOEVOLUTURE
XEROPHILIA
XOXER
ZERO KNOWLEDGE PROOF
This may not be the best possible neologism for this sort of entity, but I think it’s a good idea on principle to generate neologisms. They are good for us and solidify our thinking. Bruce Sterling, Speech at Lifelike Computer Characters ‘95.
Experts at Adelaide’s Flinders University have made an Alzheimer’s breakthrough that may result in world’s first dementia vaccine. Developed by Australian and US scientists, this vaccine may not only prevent but also reverse early stages of Alzheimer’s, the most common form of dementia.
The Alzheimer’s vaccine may be tested on humans within the next two to three years after being bankrolled by the US Government. Scientists from Flinders University and America’s Institute of Molecular Medicine and University of California developed the vaccine by targeting proteins in the brain that block neurons.
The formula targets tau proteins and abnormal beta-amyloid that cause Alzheimer’s. The scientists are confident that the vaccine would eventually be used as preventative vaccine. According to Flinders University medicine professor Nikolai Petrovsky, the proteins must be removed from the brain as Alzheimer’s, and dementia sufferers have lots of these broken down proteins inside.
The SV trend.
Employees at San Francisco startup Nootrobox don’t eat on Tuesdays.
The weekly fast isn’t an extreme money-saving move by a scrappy, bootstrapping company. Instead, Nootrobox team members swear withholding food for 36 hours — they stop eating Monday night — improves their workplace focus and concentration.
“We’re actually super productive on Tuesdays,” co-founder and CEO Geoffrey Woo said. “It’s hard at first, but we literally adopted it as part of the company culture.”
Is it time for rehab for junk food junkies?
Apparently, all the burgers and smoothies you’re consuming cause your brain to forget to stop eating even when you’re full.
Can you relate to midnight cravings and the feeling of perpetual hunger? Do you resort to grabbing fast food on the fly or eating out of a tub of ice cream while you’re bored around the house?
New research reveals obesity may be a brain disease that worsens in people with a diet high in sugar and fat. People who are diet conscious and eat healthy are less likely to indulge in sweet cravings and unhealthy snacks, since their brain recalls a sense of fulfillment derived from watching what they eat. Consuming sugars and fats hinders the functioning of the hippocampus area of one’s brain, blocking from their mind the memories of when their stomach felt full.
Alfred G. Knudson Jr., a medical researcher who helped decode a mystery of cancer — using genetics, mathematics and intuition to explain how and why certain forms of the disease attack — died July 10 at his home in Philadelphia. He was 93.
His death was announced by the Fox Chase Cancer Center in Philadelphia, where Dr. Knudson had served as president, scientific director and in other capacities since joining the institution in 1976. He had heart ailments and dementia, said his wife, Anna Meadows, a pediatric oncologist.
Dr. Knudson was among the most renowned researchers in his field, with honors including a 1998 Lasker Award, commonly known as the American Nobel, and a 2004 Kyoto Prize recognizing him for a discovery that “opened a new horizon in modern cancer genetics and played a pivotal role in the major developments” in cancer research.
The Allen Brain Observatory is open for business, revealing what’s running through the mind of a mouse as it sees patterns of light and dark, pictures of butterflies and tigers – or even the opening scene of Orson Welles’ 1958 classic film, “Touch of Evil.”
The online repository of 30 trillion bytes’ worth of brain-cell readings represents the latest scientific offering from the Allen Institute for Brain Science, funded by Microsoft co-founder Paul Allen. It follows through on a $300 million pledge that Allen made more than four years ago.
The Allen Institute’s president and chief scientific officer, Christof Koch, has compared the project to a Hubble Space Telescope for the brain.
Ray Kurzweil is a celebrity technologist, well known both for his work as an inventor and for his relatively accurate predictions of technological change. Among his predictions is that of an imminent biotech revolution, which may enable people to restore and maintain healthy life for much longer periods of time than those humans have enjoyed historically. In the meantime, Ray says he takes 250 dietary supplements each day, in addition to receiving half a dozen intravenous therapies each week.
“Although my program may seem extreme, it is actually conservative – and optimal (based on my current knowledge). [My doctor] and I have extensively researched each of the several hundred therapies that I use for safety and efficacy. I stay away from ideas that are unproven or appear to be risky (the use of human-growth hormone, for example).” – Ray Kurzweil in The Singularity Is Near (pages 211–212)
Some of Ray’s dietary supplements are nootropics, intended to maintain and improve brain health. He lists them in his book, Transcend (pages 15 and 22). I’ve compared the nootropics he recommends to reviews on Examine.com, an independent and unbiased encyclopedia on supplementation and nutrition that is not affiliated in any way with any supplement company. Below is a table that summarizes what I found, followed by some observations.
(NaturalNews) Earlier this month, Juno Therapeutics, a pioneer in the field of treating cancer using genetically engineered cells, had to halt the development of its lead treatment after the death of three leukemia patients enrolled in the study.
The Seattle-based biotech company reported that the deaths of all three patients, who were in their 20s, were linked to swelling in the brain. The swelling occurred after the company added a second chemotherapy drug to the treatment procedure.
The news of the patient deaths is a big blow for the biotech startup that is developing a new experimental therapy known as chimeric antigen receptor T-cell (or CART) immunotherapy. The setback will likely delay the company’s aim of introducing it to the market by 2017, Juno executives said in a conference.